Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationHematopoietic Stem Cell TransplantationHematopoietic Stem CellsBone and BonesTransplantation ConditioningLeukemiaAnemia, AplasticTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanHematopoiesisBone Marrow PurgingHistocompatibility TestingMice, Inbred C57BLHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesT-LymphocytesKidney TransplantationHematologic NeoplasmsRadiation ChimeraRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteCombined Modality TherapyImmunosuppressive AgentsTime FactorsTreatment OutcomeBone Marrow ExaminationGraft RejectionRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, MyeloidColony-Forming Units AssayHepatic Veno-Occlusive DiseaseTransplantation ImmunologyBone RemodelingImmunosuppressionCell DifferentiationBone Marrow NeoplasmsAcute DiseaseLymphocyte DepletionGraft vs Host ReactionMice, Inbred BALB CStem Cell TransplantationLymphoma, Non-HodgkinSpleenLeukocyte TransfusionFlow CytometryChimeraSevere Combined ImmunodeficiencyHeart TransplantationCells, CulturedHLA AntigensMyelodysplastic SyndromesSurvival AnalysisRetrospective StudiesAntigens, CD34Mice, KnockoutHematologic DiseasesCyclosporineLymphocyte TransfusionLung TransplantationGraft vs Tumor EffectActuarial AnalysisBone DensityLymphocyte ActivationImmune ToleranceCarmustineAntineoplastic Combined Chemotherapy ProtocolsGraft vs Leukemia EffectAntigens, CDLeukocyte CountPancytopeniaNuclear FamilyGranulocyte Colony-Stimulating FactorSurvival RateCytomegalovirus InfectionsFollow-Up StudiesOrgan TransplantationGranulocytesImmune SystemCytarabineCell SeparationHematopoietic SystemBlood CellsB-LymphocytesLymphomaDisease-Free SurvivalMice, TransgenicMultiple Myeloma